Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Carcinoma, Adenoid Cystic
×
tislelizumab
×
Clear all
Filters
3
NCT03287427
2023-02-15
MYPHISMO
Peter MacCallum Cancer Centre, Australia
Phase 1
Completed
27 enrolled